N6-methyladenosine (m6A) is a dynamic post-transcriptional RNA modification influencing all aspects of mRNA biology. While m6A modifications during numerous viral infections have been described, the role of m6A in innate immune response remains unclear. Here, we examined cellular m6A epitranscriptomes during infections of Pseudomonas aeruginosa and herpes simplex virus type 1 (HSV-1), and lipopolysaccharide (LPS) stimulation to identify m6A-regulated innate immune response genes. We showed that a significant portion of cellular genes including many innate immune response genes underwent m6A modifications in 5'UTR and 3'UTR. We identified common and distinct m6A-modified genes under different stimulating conditions. Significantly, the expression of a subset of innate immune response genes was positively correlated with m6A level. Importantly, we identified genes that had significant enrichments of m6A peaks during P. aeruginosa infection following knockdown of m6A “eraser” ALKBH5, confirming the regulation of these genes by m6A and ALKBH5. Among them, we confirmed the association of m6A modification with gene expression in immune response genes TNFAIP3, IFIT1, IFIT2 and IFIH1. Taken together, our results revealed the vital role of m6A in regulating innate immunity against bacterial and viral infections. These works also provided rich resources for the scientific community.
Innate immunity, the first line of defense against infection, relies on pattern recognition receptors (PRRs) to sense pathogens by recognizing pathogen-associated molecular patterns (PAMPs) [1, 2]. PRRs react with specific PAMPs to activate different signaling pathways, leading to distinct anti-pathogen responses  including interferon (IFN)-stimulated genes (ISGs) .
Discovered in 1970s , N6-methyladenosine (m6A) methylation is the most abundant internal modification occurring in RNAs of most eukaryotes . Regulation by m6A is dynamic and reversible, which is executed by methyltransferases (“writers”) [7, 8], demethylases (“erasers”) including alkB homolog 5 (ALKBH5) and fat mass and obesity associated (FTO) [9, 10], m6A-binding proteins (“readers”) [11,12,13], and proteins that preferentially bind to mRNAs in the absence of m6A (“anti-readers”) [14, 15]. m6A modification on RNA not only participates in RNA metabolism but is also involved in diverse biological functions [9, 10]. Almost every aspect of RNA biology is affected by m6A modification, including structure, maturation, stability, splicing, export, translation and decay . The advent of m6A sequencing (m6A-seq) has given rise to the field of epitranscriptomics .
The interaction between virus and host is regulated by m6A . m6A modifications are present in genomes of RNA viruses and transcripts of DNA viruses, which regulate viral gene expression and replication [19,20,21,22]. Furthermore, m6A epitranscriptomes in host cells are altered upon viral infections resulting in either enhanced infection or host resistance .
m6A regulates innate immunity upon viral infection. During vesicular stomatitis virus infection, RNA helicase DDX46 recruits ALKBH5 to erase m6A from MAVS, TRAF3 and TRAF6 transcripts , increasing their nuclear retention and resulting in severe attenuation of antiviral type I IFN response . During herpes simplex virus-1 (HSV-1) infection, hnRNPA2B1 blocks FTO access to cGAS, IFI16 and STING transcripts, thereby increasing methylation level and nuclear export, resulting in a stronger antiviral response . Upon viral infection, host cells impair ALKBH5 enzymatic activity to increase m6A methylation on α-ketoglutarate dehydrogenase (OGDH) mRNA resulting in reduced mRNA stability, protein expression, and decreased production of metabolite itaconate required for viral replication . Consequently, ALKBH5-deficient mice display an innate immunity-independent resistance to viral challenge .
In contrast to viral infection, there is few study on the role of m6A during bacterial infection. In this study, we systematically compared cellular m6A epitranscriptomes during bacterial and viral infections, and identified common and unique m6A-regulated innate immune response genes, providing further insights into the biological roles of m6A modifications.
m6A epitranscriptome in bacterial infection
Macrophages are robust effector cells of innate immunity and have a central role in host defense against bacterial infection . We infected mouse macrophage RAW264.7 cells with Gram-negative bacteria P. aeruginosa for 0, 2, 4 and 6 h. Cluster analysis of input and m6A-immunoprecipitation (m6A-IP) samples from two independent experiments showed grouping by time points, indicating experimental consistency (Supplementary Fig. 1). Analysis with ExomePeak  revealed >3000 upregulated or downregulated genes at any time points (Supplementary Fig. 2A). However, there were substantially fewer differential m6A methylated genes (DMs) with 524, 449 and 410 hypermethylated genes, and 1159, 1191 and 885 hypomethylated genes at 2, 4 and 6 h, respectively (Supplementary Fig. 2B), suggesting regulation of only some differentially expressed genes by m6A, and that there were about 2-fold more hypomethylated than hypermethylated genes.
We identified 2271 (43.56%) and 1857 (36.21%) upregulated and downregulated genes at all time points, respectively, indicating consistency of most altered genes (Fig. 1A). However, only 101 (10.50%) and 228 (9.78%) genes were consistently hypermethylated and hypomethylated, respectively, at all the time points, indicating more dynamic m6A alterations during bacterial infection (Fig. 1B).
Analysis of m6A transcript distribution revealed more m6A losses at 5'UTR and more m6A gains at 3'UTR on mRNA following P. aeruginosa infection (Fig. 1C). There were also more m6A losses at 5' end and more m6A gains from the middle region to 3' end on lncRNA (Fig. 1C).
To identify m6A-regulated differentially expressed genes (DEs), we overlapped DEs with differentially methylated genes (DMs). There were 60 and 75 upregulated genes that were differentially hypermethylated and hypomethylated, respectively, and 7 and 73 downregulated genes that were differentially hypermethylated and hypomethylated, respectively, at all the time points (Fig. 1D). Clearly, there were fewer hypermethylated downregulated genes than all other groups.
Gene Set Enrichment Analysis revealed that among DEs, numerous immune response pathways including Immune system and Cytokine signaling in the immune system were highly enriched, and that these pathways were upregulated following bacterial infection (Supplementary Fig. 3A and Supplementary Table 1). Among DMs, these two pathways were also enriched besides several other immune response pathways (Supplementary Fig. 3B and Supplementary Table 2). Among DEs that were also DMs (DEDMs), several immune response pathways including numerous Toll-like receptor (TLR) pathways were enriched (Supplementary Fig. 3C and Supplementary Table 3). Particularly, the major innate immune response TLR4 pathway in bacterial infection was enriched.
Examination of DEDMs revealed high degree of positive correlation at all time points between levels of DEs and levels of differential methylation (r = 0.2588, p = 4.33E−21 at 2 h; r = 0.4071, p = 1.75E−56 at 4 h; and r = 0.4499, p = 2.03E−53 at 6 h in Fig. 1E). This trend was also present for immune response genes (r = 0.1533, p = 0.0459 at 2 h; r = 0.4651, p = 2.93E−09 at 4 h; r = 0.3714, p = 1.47E−05 at 6 h in Fig. 1E). These results indicated that m6A might have a critical role in innate immune response to bacterial infection.
m6A epitranscriptome following LPS treatment
Since the TLR4 pathway is primarily activated by LPS in Gram-negative bacteria , we examined m6A epitranscriptome following treatment of RAW264.7 cells with LPS for 6 h, which induced maximal innate immune response.
We identified 5874 upregulated and 2446 downregulated genes (Supplementary Fig. 4), and 3157 hypermethylated and 3226 hypomethylated genes (Supplementary Fig. 4). Similar to bacterial infection, there were more m6A losses at 5'UTR and more m6A gains at 3'UTR on mRNA (Fig. 2A). There were also more m6A losses at 5' end and more m6A gains at 3' end on lncRNA (Fig. 2A). Among the upregulated genes, there were more hypermethylated than hypomethylated genes (628 vs 329). In contrast, among the downregulated genes, there were fewer hypermethylated than hypomethylated genes (1246 vs 1884) (Fig. 2B).
As expected, among DEs, numerous immune response pathways were enriched, and upregulated by LPS treatment (Supplementary Fig. 5A and Supplementary Table 4). Among DMs, numerous TLR4-related pathways were highly enriched (Supplementary Fig. 5B and Supplementary Table 5). Among DEDMs, TLR4-related pathways remained enriched (Supplementary Fig. 5C and Supplementary Table 6), suggesting they were regulated by m6A. We also observed correlation between levels of DEs and levels of differential methylation (r = 0.4367, p = 3.28E−153 in Fig. 2C), including immune response genes (r = 0.4537, p = 2.08E−151 in Fig. 2C).
HSV-1 infection alters cellular m6A epitranscriptome
To identify cellular genes regulated by m6A during viral infection, we used a common human pathogen HSV-1 to infect the highly permissive HeLa cells at 5 multiplicities of infection (MOIs) for 5 and 8 h. Over 4000 DEs were identified at both time points (Supplementary Fig. 6A). However, there were fewer DMs with 1339 and 2367 hypermethylated genes, and 729 and 1412 hypomethylated genes at 5 and 8 h, respectively (Supplementary Fig. 6B), suggesting that the expression of close to 50% of genes were directly or indirectly regulated by m6A, and there were more hypomethylated than hypermethylated genes.
We identified 3640 (66.79%) upregulated and 3377 (58.14%) downregulated genes at both 5 and 8 h, respectively, indicating persistent alterations of a large portion of these genes (Fig. 3A). Unlike bacterial infection, as many as 512 (40.25%) and 845 (41.20%) genes were consistently hypermethylated and hypomethylated at 5 and 8 h, respectively, indicating most of the genes were persistently regulated by m6A (Fig. 3B). Unlike bacterial infection, we observed m6A gains at both 5'UTR and 3'UTR on mRNA (Fig. 3C). m6A gains were also observed at 5' end on lncRNA; however, there were more m6A losses at 3' end on lncRNA (Fig. 3C). Among the upregulated genes, there were more hypomethylated than hypermethylated genes (269 vs 87) (Fig. 3D). However, among the downregulated genes, there were similar hypomethylated as hypermethylated genes (83 vs 97) (Fig. 3D). Interestingly, we did not observe enrichment of any immune response pathways among DEs (Supplementary Fig. 7A and Supplementary Table 7), DMs (Supplementary Fig. 7B and Supplementary Table 8), or DEDMs (Supplementary Fig. 7C and Supplementary Table 9) albeit numerous immune response DEs and DMs were detected. Furthermore, we only observed a negative correlation between levels of DEs and levels of differential methylation at 8 h but not 5 h (r = −0.0686, p = 0.1087 at 5 h; r = −0.3085, p = 0.0036 at 8 h in Fig. 3E), including immune response genes (r = −0.0311, p = 0.1082 at 5 h; r = −0.0484, p = 0.0044 at 8 h in Fig. 3E). These results suggest regulation of innate immune response by m6A at a later time point. It is known that HSV-1 encodes numerous inhibitory proteins of innate immunity , which might affect m6A’s role during HSV-1 infection.
Common DEDMs during bacterial and viral infections
We further identified common genes regulated by m6A during bacterial and viral infections, and LPS treatment. As expected, there were clearly more common DEDMs between P. aeruginosa infection and LPS treatment than between P. aeruginosa and HSV-1 infections, or LPS treatment and HSV-1 infection (Fig. 4A, Supplementary Table 10). This could be due to the distinct responses to different stimulations. However, the use of different cells might also contribute to the variations. When considering DEDMs at any time points during bacterial and viral infections, and LPS treatment, we identified 65 common genes (Fig. 4A, Supplementary Table 10). However, we failed to find any enriched pathways for these genes, which could be due to the small gene number. When we analyzed overlapped DEDMs between two conditions including bacterial and HSV-1 infections, and LPS treatment and HSV-1 infection, we obtained 5 enriched pathways including the Immune system pathway (Fig. 4B). Hence, m6A might regulate distinct sets of immune response genes between viral and bacterial infections, or between viral infection and LPS treatment.
ALKBH5 knockdown enhances innate immune responses during bacterial infection
To identify genes directly regulated by m6A, we performed knockdown of m6A writers or erasers. Unfortunately, we were unable to achieve efficient knockdown of METTL3 and METTL14 without causing severe cellular toxicity. However, we achieved efficient ALKBH5 knockdown (Supplementary Fig. 8A) in RAW264.7 cells, which were infected with P. aeruginosa for 6 h and subjected to m6A profiling (Supplementary Fig. 8B). We identified 340 upregulated and 263 downregulated genes (Fig. 5A and Supplementary Fig. 9A). Among them, numerous immune response pathways were enriched (Fig. 5B), indicating ALKBH5 knockdown enhances immune response, most likely through regulating m6A levels on these transcripts. While we identified 850 hypermethylated genes, there were also 1458 hypomethylated genes, which might be regulated by other indirect mechanisms (Fig. 5C and Supplementary Fig. 9B). The fact that there were significantly more DMs than DEs suggested that not all m6A alterations were translated into DEs. Importantly, we found that most enriched pathways of DMs were related to immune responses (Fig. 5D), further confirming the regulation of immune response by ALKBH5 during bacterial infection.
ALKBH5 regulates DEDMs during bacterial and viral infections
Next, we examined DEDMs following ALKBH5 knockdown. Because there were few overlapped genes between viral infection and bacterial infection or LPS treatment, we included genes mutually regulated by bacterial infection and LPS treatment, and those mutually regulated by bacterial and viral infections. We found that, at all time points of bacterial infection, >50% of DEDMs had m6A hypomethylation following ALKBH5 knockdown (Fig. 5E), suggesting an indirect role of ALKBH5. Nevertheless, 37.61%, 44.89% and 37.41% of the DEDMs were hypermethylated at 2, 4 and 6 h post-infection, respectively, following ALKBH5 knockdown (Fig. 5E). These genes were likely directly regulated by ALKBH5 and m6A. Among DEDMs during viral and bacterial infections, or bacterial infection and LPS treatment, ≥50% of them did not have any expression changes following ALKBH5 knockdown (Fig. 5F). However, 30.58%, 26.32% and 21.77% of these genes were upregulated while 19.57%, 18.58% and 24.15% of them were downregulated following ALKBH5 knockdown when presented by 2, 4 and 6 h following bacterial infection, respectively (Fig. 5F). As expected, most genes impacted by ALKBH5 knockdown were those upregulated during viral and bacterial infections, or bacterial infection and LPS treatment (Fig. 5G). A large portion of the upregulated and hypermethylated genes at 2 and 4 h were further upregulated following ALKBH5 knockdown (Fig. 5G), suggesting an important role of m6A hypermethylation for inducing these genes during bacterial and viral infections. Nevertheless, a consistent fraction of the upregulated and hypermethylated genes (15–35%) at all the time points during bacterial infection were indeed downregulated following ALKBH5 knockdown (Fig. 5G), suggesting a negative regulatory role of m6A hypermethylation for these genes. Similarly, a fraction of the upregulated and hypomethylated genes (12–24%) at all the time points were also downregulated following ALKBH5 knockdown (Fig. 5G), suggesting a role of m6A hypomethylation in inducing these genes. However, a subset of the upregulated and hypomethylated genes (15–25%) at all the time points were upregulated following ALKBH5 knockdown (Fig. 5G), suggesting a negative regulatory role of m6A hypomethylation in these genes. Of interest, upregulated and hypomethylated genes were mostly impacted by ALKBH5 knockdown at a later time point of infection (6 h) (Fig. 5G). Together, these results revealed the complex dynamics and function of m6A during bacterial and viral infections.
Confirmation of m6A-regulated immune response genes
Among DEDMs, those with hypermethylation and upregulation were the most common genes regulated by ALKBH5 during bacterial and viral infections (Fig. 5G). We identified a set of these immune response genes, including IFIH1, TNFAIP3, IFIT1 and IFIT2. ALKBH5 knockdown further increased the expression of these genes during P. aeruginosa or HSV-1 infection, or LPS treatment in RAW264.7 cells (Fig. 6A and Supplementary Fig. 10). We detected increased m6A levels of these genes following ALKBH5 knockdown (Fig. 6B). Hence, IFIH1, TNFAIP3, IFIT1 and IFIT2 were the common immune response genes regulated by m6A during bacterial or viral infection, or LPS treatment.
We determined the mechanism mediating m6A regulation of IFIH1, TNFAIP3, IFIT1 and IFIT2. Examination of transcript splicing pattern and nuclear export did not reveal any consistent alteration. However, RNA stability of IFIH1, TNFAIP3 and IFIT2 transcripts was altered following ALKBH5 knockdown with IFIH1 and TNFAIP3 transcripts having significant extended half-lives while IFIT2 transcript having a significant shorter half-life (Fig. 6C). No consistent change of half-life was observed for IFIT1 following ALKBH5 knockdown. These results confirmed the regulation of IFIH1, TNFAIP3, IFIT1 and IFIT2 by ALKBH5 and m6A with distinct mechanisms during both bacterial and viral infections.
We have analyzed m6A epitranscriptomes following P. aeruginosa and HSV-1 infections as well as LPS treatment. Firstly, we have observed more DEs than DMs in all three conditions, indicating that m6A only regulates a fraction of DEs. Secondly, there are almost 4 times more DMs than DEs during bacterial infection following ALKBH5 knockdown, indicating that m6A alterations do not always lead to differential gene expression. Thirdly, there are more altered m6A peaks in 5'UTR and 3'UTR than other regions of the transcripts. Hypomethylation predominantly occurs in 5'UTR and hypermethylation predominantly occurs in 3'UTR during bacterial infection and LPS treatment. Similar observations were previously reported in heatshock and invasive malignant pleomorphic adenoma [31,32,33]. It is known that 5'UTR regulates mRNA translation and 3'UTR mediates mRNA stability [34, 35]. Interestingly, m6A hypermethylation occurs in both 5'UTR and 3'UTR during HSV-1 infection. It is likely that m6A alterations in 5'UTR and 3'UTR might mediate important cellular responses during bacterial and viral infections.
There are large numbers of overlapping DEDMs between P. aeruginosa infection and LPS treatment as expected. LPS is the major PAMP of Gram-negative bacteria such as P. aeruginosa, inducing robust innate immune response. Indeed, both DEs and DMs are significantly enriched in pathways related to innate immune responses following P. aeruginosa infection and LPS treatment. Significantly, we have found that the levels of DEs is positively correlated with differential methylation levels. A similar correlation is also present for immune response genes alone. Hence, m6A might function to promote gene expression, particularly rapidly induced immune response genes. However, it is also possible that m6A might function as a feedback mechanism to control the expression of these genes. Indeed, among these genes, we have identified both upregulated and downregulated genes following ALKBH5 knockdown (Fig. 5G), suggesting the existence of both mechanisms. m6A is known to mediate mRNA degradation through reader proteins YTHDF2, YTHDF3 and YTHDC2 [12, 13, 36, 37]. The mechanism of m6A positive regulation of gene expression remains to be elucidated. Regardless of the mechanism involved, m6A is likely essential for regulating cellular response including immune response to bacterial infection and LPS treatment.
In contrast, we have found few overlapped DEDMs between HSV-1 infection and P. aeruginosa infection or LPS treatment. We have also failed to detect a correlation between levels of DEs and differential methylation levels following HSV-1 infection albeit there is a weak negative correlation for immune response genes. It is possible that HSV-1 infection might trigger a distinct cellular response including an immune response. Indeed, HSV-1 encodes numerous inhibitory genes of innate immune response . It remains possible that HSV-1 genes might directly interfere with m6A-related complexes to upsurge m6A functions.
To confirm genes directly regulated by m6A during P. aeruginosa infection, we have performed ALKBH5 knockdown. Among DEs caused by ALKBH5 knockdown, over one-third are hypermethylated. However, two-third of them are hypomethylated, which are likely regulated by other unknown mechanisms. Among DEDMs caused by ALKBH5 knockdown, pathways related to immune response genes are significantly enriched during P. aeruginosa infection, confirming m6A’s important role in regulating the expression of these genes.
By focusing on overlapped DEDMs between bacterial and viral infections, or bacterial infection and LPS treatment, we have identified sets of hypermethylated and hypomethylated genes that are either upregulated or downregulated following ALKBH5 knockdown. However, we have found that over 50% of these genes are both hypermethylated and upregulated, confirming the important positive regulatory role of m6A in the expression of these genes. We have confirmed the hypermethylation and upregulation of numerous innate immune response genes including IFIH1, TNFAIP3, IFIT1 and IFIT2 following ALKBH5 knockdown during bacterial and viral infections as well as LPS treatment, indicating that these genes might be universally regulated by m6A during bacterial and viral infections. While the reduced IFIT2 transcript stability is expected following ALKBH5 knockdown and an increase in m6A level, we have also found increased stability of TNFAIP3 and IFIH1 transcripts. It would be interesting to further investigate how the increased m6A modifications and ALKBH5 knockdown stabilize these transcripts. The mechanism of m6A enhancement and ALKBH5 reduction of IFIT1 expression is also unclear.
In summary, we have mapped m6A epitranscriptomes during bacterial and viral infections, and LPS stimulation, and identified m6A- and ALKBH5-regulated common and distinct innate immune response genes including a set of genes with positive correlation of expression with m6A level. These results reveal the important roles of m6A and ALKBH5 in innate immune response, and provide rich resources for the scientific community.
Materials and methods
Bacteria, virus and cells
P. aeruginosa were purchased from ATCC; Herpes simplex virus type 1 (HSV-1, F strain) was a gift from Dr. David Johnson (Oregon Health Science University, Portland, OR); RAW 264.7 and HeLa cells were purchased from ATCC and cultured following the instructions provided by ATCC.
Infection and LPS treatment
RAW264.7 cells at 4 × 105 cells per mL were infected with P. aeruginosa at 107 per mL and harvested at the indicated time point. RAW264.7 cells at 4 × 105 cells per mL were treated with LPS at 1 μg/mL and harvested at 6 h post-treatment. HeLa cells were infected with HSV-1 at 5 MOIs and harvested at 5 or 8 h post-infection.
Isolation of m6A-containing fragments was performed as previously described with minor modifications . Briefly, total RNA was extracted from cells using TRI Reagent (T9424-200ML, Sigma-Aldrich). The total RNA was fragmented using an RNA fragmentation kit (AM8740, ThermoFisher). Successful fragmentation of RNA with sizes close to 100 nucleotides was validated using a bioanalyzer (2100 bioanalyzer instrument, Agilent). Anti-m6A antibody (10 µg) (202-003, Synaptic Systems) was incubated with 30 µl slurry of Pierce Protein A Agarose beads (20365, ThermoFisher) by rotating in 250 µl PBS at 4 °C for 3 h. The beads were washed three times in cold PBS followed by one wash in an IP buffer containing 10 mM Tris-HCl at pH 7.4, 150 mM NaCl and 1% Igepal CA-630 (I8896-50ML, Sigma-Aldrich). To isolate the m6A-containing fragments, 120 µg of fragmented total RNA was added to the antibody-bound beads in 250 µl IP buffer supplemented with RNasin Plus RNase inhibitor (PRN2615, Promega), and the mixture was incubated at 4 °C for 2 h. The beads were washed seven times with 1 ml IP buffer and eluted with 100 µl IP buffer supplemented with 6.67 mM of m6A salt (M2780, Sigma-Aldrich) for 1 h at 4 °C. A second elution was carried out and the eluates were pooled together before purification with ethanol 70% precipitation.
Purified eluate and input samples were used to generate complementary DNA libraries for m6A-seq. Approximately 25 ng was used for library preparation for RNA sequencing (RNA-seq) using the KAPA Stranded RNA-Seq Kit with RiboErase (HMR) sample preparation guide (KAPA Biosystems) according to the instructions of the manufacturer with two modifications. First, the elute-frag-prime stage was done at 85 °C for 2 min to allow annealing without causing fragmentation. RNA was reverse transcribed into first-strand cDNA using reverse transcriptase and random primers. This was followed by the second strand cDNA synthesis using DNA Polymerase I and RNase H. The cDNA fragments then went through an end repair process with the addition of a single ‘A’ base followed by ligation of adapters. The products were then purified and enriched by PCR amplification for ten cycles to generate the final RNA-seq library. Secondly, beads/DNA ratio of 1:3 instead of 1:1 was used to preserve smaller fragments during the adapter ligation double beads clean-up step. cDNA libraries were quantified and pooled for cBot amplification and subsequent sequencing on an Illumina HiSeq 3000 platform 50 bp single read sequencing module. After the sequencing run, demultiplexing with Bcl2fastq2 was employed to generate a fastq file for each sample.
m6A-seq data analysis
m6A-seq data analysis was performed as previously described . Reads of the IP/Input samples were aligned to the corresponding genomes using Tophat2 Aligner v2.0.6, which implicitly calls Bowtie2 with default options. Following this, peak calling and differential m6A/m methylation analyses were performed using the exomePeak R/Bioconductor package, a software specifically designed for m6A analysis. The peak calling is based on the Przyborowski and Wilenski method, which compares the means of two Poisson distributions (c-test), which computes the methylation enrichment of normalized IP reads over normalized input reads (or mRNA abundance) as the test statistics. Only the loci that show significant methylation enrichment are determined as peak regions. For analysis of differential m6A peaks, the fold changes of methylation enrichments between two conditions are calculated and a rescaled hypergeometric test is applied to determine the significance of differential fold enrichment. The output of exomePeak includes the loci of the (differential) m6A/m peaks, the gene symbol of the transcripts to which peaks localize, the detection P values, false discovery rates (FDR) and methylation enrichment (for peak calling) or enrichment fold-change (for differential m6A analysis). For both m6A peak calling and differential peak discovery, an FDR threshold of 0.05 is used. m6A peaks were annotated with identifiers such as Gene Symbol and RefSeq ID as well as regional overlapping status (5'UTR/coding DNA sequence/3'UTR). Regional distribution of m6A was plotted using the Guitar package. Motif analysis of m6A peaks was performed using the MEME package.
To investigate the methylation behavior of genes across samples, the highest fold enrichment among all peaks within a gene was considered as the methylation fold enrichment of the gene. Hierarchical clustering with Euclidean distance was used to group similarly methylated genes according to samples.
Gene expression analysis
The expression of transcripts and isoforms and differential expression levels were calculated using cufflinks and cuffdiff, respectively, based on the input samples. To avoid underestimating the expression of genes, we used reads mapped to the cellular genome to calculate the fragments per kilobase of transcript per million mapped reads (FPKM). All the other bioinformatics analyses were performed on Matlab, R or Perl.
siRNA silencing was performed as previously described . Briefly, RAW264.7 cells were transfected with 2.5 pmol of each siRNA per well in a 12-well plate using Lipofectamine RNAi Max (13778150, ThermoFisher) according to manufacturer’s instructions. Two days after transfection, the cells were monitored for knockdown efficiency of the target gene by RT-qPCR and Western-blotting, and infected by indicated pathogen for the indicated time. siRNAs purchased from Sigma-Aldrich are as follows:
ALKBH5 si1: SASI_Mm01_00106232;
ALKBH5 si2: SASI_Mm02_00344968;
ALKBH5 si3: SASI_Mm01_00106233; and
si Negative Control (siNC): Sigma siRNA Universal Negative Control #1 (SIC001-10NMOL).
RNA stability assay
For RNA stability assays, actinomycin D (10 μg/ml) (A9415-2MG, Sigma-Aldrich) was added to inhibit transcription. RNA isolated at 0, 2, 4 and 6 h after actinomycin D treatment. Total RNA was isolated using Trizol, quantified by RT-qPCR.
RT-qPCR for gene expression and MeRIP-qPCR for m6A-seq validation
RT-qPCR for gene expression and MeRIP-qPCR for m6A-seq validation was carried out as previously described . Total RNA was isolated with TRI Reagent (T9424-200ML, Sigma-Aldrich) according to the manufacturer’s protocol. Reverse transcription was performed with 1 µg of total RNA using Maxima H Minus First Strand cDNA Synthesis Kit (Cat.# K1652, ThermoFisher). Quantitative PCR was done using SsoAdvanced Universal SYBR Green Supermix (1725271, Bio-Rad) and analyzed with real-time PCR machine (CFX Connect Real-Time PCR System, Bio-Rad). Relative gene expression levels were obtained by normalizing the cycle threshold (CT) values to yield 2-ΔΔCt values. For validation of m6A-seq, eluted or input mRNA was subjected to RT-qPCR. Fold enrichment was calculated by calculating the 2-ΔCt of eluate relative to the input sample. The primers used for gene expression are: 5'AAGAGCTGCTTGCACCACAC3' (forward) and 5'GTGCCACAATATGCCTGCAA3' (reverse) for IFIT1; 5'ATCTCCACCTACGGCTGACT3' (forward) and 5'TTACTGCATGGGGAAGCGAG3' (reverse) for IFIT2; 5'ACATCATGCACTGCCGGTAA3' (forward) and 5'CACAGCCATGACCATCAGGT3' (reverse) for TNFAIP3; 5'CCAGGGTCCAAATTCGCCTT3' (forward) and 5'GTACCCGGCATGGGAAGATG3' (reverse) for IFIH1; and 5'CCCTGAAGTACCCCATTGAA3' (forward) and 5'GGGGTGTTGAAGGTCTCAAA3' (reverse) for β-actin.
Protein samples were lysed in Laemmli buffer, separated by SDS-PAGE and transferred to a nitrocellulose membrane . The membrane was blocked with 5% milk and then incubated with primary antibody to GAPDH (5174 s, CST) or ALKBH5 (HPA007196, Sigma) overnight at 4 °C. The membrane was washed with TBS-Tween and probed with a secondary antibody conjugated to horseradish peroxidase (HRP). After further washing with TBS-T, the blot was visualized with SuperSignal™ West Femto Maximum Sensitivity Substrate (34096, Thermo) and imaged on a ChemiDoc™ MP Imaging System (12003154, Bio-Rad).
All RNA-seq data are available are available at GenBank accession#: GSE196272 at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196272
All data needed to evaluate the conclusions in the paper are present in the paper. Additional data related to this paper may be requested from the corresponding author.
Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T, et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol. 2003;171:4984–9.
Hornung V, Latz E. Intracellular DNA recognition. Nat Rev Immunol. 2010;10:123–30.
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801.
Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197–216.
Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA. 1974;71:3971–5.
Brocard M, Ruggieri A, Locker N. m6A RNA methylation, a new hallmark in virus-host interactions. J Gen Virol. 2017;98:2207–14.
Bujnicki JM, Feder M, Radlinska M, Blumenthal RM. Structure prediction and phylogenetic analysis of a functionally diverse family of proteins homologous to the MT-A70 subunit of the human mRNA:m(6)A methyltransferase. J Mol Evol. 2002;55:431–44.
Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28:616–24.
Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol cell 2013;49:18–29.
Wei J, Liu F, Lu Z, Fei Q, Ai Y, He PC, et al. Differential m(6)A, m(6)Am, and m(1)A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol Cell. 2018;71:973–85.
Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol cell. 2016;61:507–19.
Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu PJ, et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 2017;27:315–28.
Du H, Zhao Y, He J, Zhang Y, Xi H, Liu M, et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun. 2016;7:12626.
Edupuganti RR, Geiger S, Lindeboom RGH, Shi H, Hsu PJ, Lu Z, et al. N(6)-methyladenosine (m(6)A) recruits and repels proteins to regulate mRNA homeostasis. Nat Struct Mol Biol. 2017;24:870–78.
Li Z, Qian P, Shao W, Shi H, He XC, Gogol M, et al. Suppression of m(6)A reader Ythdf2 promotes hematopoietic stem cell expansion. Cell Res. 2018;28:904–17.
Batista PJ, Molinie B, Wang J, Qu K, Zhang J, Li L, et al. m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2014;15:707–19.
Barranco C. Viral infection linked to m(6)A alterations in host mRNAs. Nat Rev Mol Cell Biol. 2020;21:64–65.
Tan B, Gao SJ. The RNA Epitranscriptome of DNA Viruses. J Virol. 2018;92:e00696–18.
An S, Huang W, Huang X, Cun Y, Cheng W, Sun X, et al. Integrative network analysis identifies cell-specific trans regulators of m6A. Nucleic Acids Res. 2020;48:1715–29.
Lichinchi G, Zhao BS, Wu Y, Lu Z, Qin Y, He C, et al. Dynamics of human and viral RNA methylation during zika virus infection. Cell Host Microbe. 2016;20:666–73.
Li N, Hui H, Bray B, Gonzalez GM, Zeller M, Anderson KG, et al. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection. Cell Rep. 2021;35:109091.
Kennedy EM, Bogerd HP, Kornepati AVR, Kang D, Ghoshal D, Marshall JB, et al. Posttranscriptional m(6)A editing of HIV-1 mRNAs enhances viral gene expression. Cell Host Microbe. 2017;22:830.
Dang W, Xie Y, Cao P, Xin S, Wang J, Li S, et al. N(6)-Methyladenosine and viral infection. Front Microbiol. 2019;10:417.
Zheng Q, Hou J, Zhou Y, Li Z, Cao X. The RNA helicase DDX46 inhibits innate immunity by entrapping m(6)A-demethylated antiviral transcripts in the nucleus. Nat Immunol. 2017;18:1094–103.
Wang L, Wen M, Cao X. Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses. Science. Science. 2019;365:eaav0758
Liu Y, You Y, Lu Z, Yang J, Li P, Liu L, et al. N (6)-methyladenosine RNA modification-mediated cellular metabolism rewiring inhibits viral replication. Science. 2019;365:1171–76.
Sharma S, Fitzgerald KA. Innate immune sensing of DNA. PLoS Pathog. 2011;7:e1001310.
Meng J, Lu Z, Liu H, Zhang L, Zhang S, Chen Y, et al. A protocol for RNA methylation differential analysis with MeRIP-Seq data and exomePeak R/Bioconductor package. Methods. 2014;69:274–81.
Whitfield C, Trent MS. Biosynthesis and export of bacterial lipopolysaccharides. Annu Rev Biochem. 2014;83:99–128.
Su C, Zhan G, Zheng C. Evasion of host antiviral innate immunity by HSV-1, an update. Virol J. 2016;13:38.
Han Z, Yang B, Wang Q, Hu Y, Wu Y, Tian Z. Comprehensive analysis of the transcriptome-wide m(6)A methylome in invasive malignant pleomorphic adenoma. Cancer Cell Int. 2021;21:142.
Liu N, Parisien M, Dai Q, Zheng G, He C, Pan T. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA. RNA. 2013;19:1848–56.
Linder B, Grozhik AV, Olarerin-George AO, Meydan C, Mason CE, Jaffrey SR. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat methods. 2015;12:767–72.
Ke S, Alemu EA, Mertens C, Gantman EC, Fak JJ, Mele A, et al. A majority of m6A residues are in the last exons, allowing the potential for 3’ UTR regulation. Genes Dev. 2015;29:2037–53.
Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3’ UTRs and near stop codons. Cell. 2012;149:1635–46.
Li J, Xie H, Ying Y, Chen H, Yan H, He L, et al. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Mol Cancer. 2020;19:152.
Hsu PJ, Zhu Y, Ma H, Guo Y, Shi X, Liu Y, et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017;27:1115–27.
Tan B, Liu H, Zhang S, da Silva SR, Zhang L, Meng J, et al. Viral and cellular N(6)-methyladenosine and N(6),2’-O-dimethyladenosine epitranscriptomes in the KSHV life cycle. Nat Microbiol. 2018;3:108–20.
Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, et al. Seroconversion to antibodies against Kaposi’s sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi’s sarcoma. N Engl J Med. 1996;335:233–41.
This work was supported by grants from the National Institutes of Health (CA096512, CA124332, CA132637, CA213275, DE025465 and CA197153 to S.-J. Gao), and in part by award P30CA047904. RNA-seq and ChIP-seq data were generated by Genome Sequencing Facility at the Greehey Children’s Cancer Research Institute, which is supported by P30CA054174, an NIH Shared Instrument grant 1S10OD021805-01 (S10 grant), and a CPRIT Core Facility Award (RP160732). We thank Dr. David Johnson at Oregon Health Science University, Portland, OR for providing us the F strain HSV-1; and members of Dr. Shou-Jiang Gao’s laboratory for technical assistance and helpful discussions.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by: Professor Thomas Kaufmann
About this article
Cite this article
Feng, J., Zhang, T., Sorel, O. et al. Global profiling reveals common and distinct N6-methyladenosine (m6A) regulation of innate immune responses during bacterial and viral infections. Cell Death Dis 13, 234 (2022). https://doi.org/10.1038/s41419-022-04681-4